Ads
related to: biogen
Search results
Is Biogen Inc.'s (NASDAQ:BIIB) Recent Price Movement Underpinned By Its Weak Fundamentals?
Simply Wall St. via Yahoo Finance· 2 days agoIt is hard to get excited after looking at Biogen's (NASDAQ:BIIB) recent performance, when its stock...
RBC maintains $317 price target on Biogen stock, cites Skyclarys importance By Investing.com
Investing.com· 17 hours agoOn Wednesday, RBC (TSX:RY) Capital maintained its Outperform rating on Biogen (NASDAQ:BIIB) shares...
BIIB (Biogen Inc) may reap gains as insiders became active recently – Knox Daily
Knox Daily· 2 days agoBiogen Inc’s recently made public that its Head of Development Singhal Priya unloaded Company’s shares for reported $19817.0 on Apr 02 ’24. In the deal valued at $213.09 per ...
Biogen's new acquisition target reveals 'provocative' trial results - Boston Business Journal
The Business Journals· 2 days agoJust days after Biogen Inc. announced it was buying Human Immunology Biosciences (HI-Bio) for $1.15...
Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 6 days agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
Needham & Company LLC Reiterates “Buy” Rating for Biogen (NASDAQ:BIIB)
ETF DAILY NEWS· 6 days agoBiogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a report issued on Wednesday, Benzinga reports. Needham & Company ...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to...
FOX 23 News Albany· 6 days agoThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
...INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with...
WJTV Jackson· 6 days agoAttorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen ...
Examining the Potential Price Growth of Sangamo Therapeutics Inc
Knox Daily· 23 hours agoSangamo Therapeutics Inc’s recently made public that its 10% Owner BIOGEN INC. unloaded Company’s shares for reported $3.0 million on Sep 26 ’23. In the deal valued at $0.50 ...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by PNC Financial Services Group Inc.
ETF DAILY NEWS· 6 days agoPNC Financial Services Group Inc. reduced its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 3.0% during the 4th quarter, according to the company in its most recent ...